Definitive Healthcare Corp.
DH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | -0.00 | 2.47 | 0.80 |
| FCF Yield | 9.56% | 3.41% | 2.45% | 0.70% |
| EV / EBITDA | -1.11 | -5.21 | 52.91 | 109.97 |
| Quality | ||||
| ROIC | -70.24% | -18.70% | -1.05% | -1.36% |
| Gross Margin | 78.30% | 65.60% | 80.86% | 75.51% |
| Cash Conversion Ratio | -0.10 | -0.20 | -1.60 | -0.40 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.24% | 14.80% | 23.46% | 24.79% |
| Free Cash Flow Growth | 19.99% | 40.22% | 47.46% | -15.31% |
| Safety | ||||
| Net Debt / EBITDA | -0.26 | -0.57 | 5.50 | -5.07 |
| Interest Coverage | -47.91 | -21.69 | -3.23 | -1.05 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 4.10 | 5.55 |
| Cash Conversion Cycle | 5.26 | 61.59 | 151.53 | 119.19 |